Abstract
The objective of this study is to present a familial Cushing syndrome (CS) caused by multiple endocrine neoplasia type 1 (MEN-1)-associated thymic carcinoid. Immunohistochemistry, gene sequencing, loss of heterozygosity analysis, and Western blot were used to determine the expression of ACTH in MEN-1-related thymic tumors, MEN1 gene mutation, the pattern and extent of allelic deletion, and the expression of Menin in MEN-1-associated tumors, respectively. Tumor cells from thymus ectopic-secreted ACTH. A deletion involving the MEN1 gene locus was confirmed. The expression of Menin in MEN-1-associated tumors declined. To conclude, we presented an unusual kindred of MEN-1, which pointed out the significance of making screening of MEN-1 for both male and female patients with CS and thymic carcinoid.
Similar content being viewed by others
References
C. Larsson, B. Skogseid, K. Oberg, Y. Nakamura, M. Nordenskjold, Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332(6159), 85–87 (1988)
S.C. Chandrasekharappa, S.C. Guru, P. Manickam, S.E. Olufemi, F.S. Collins, M.R. Emmert-Buck, L.V. Debelenko, Z. Zhuang, I.A. Lubensky, L.A. Liotta et al., Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311), 404–407 (1997)
I.A. Lubensky, L.V. Debelenko, Z. Zhuang, M.R. Emmert-Buck, Q. Dong, S. Chandrasekharappa, S.C. Guru, P. Manickam, S.E. Olufemi, S.J. Marx et al., Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res. 56(22), 5272–5278 (1996)
L.V. Debelenko, Z. Zhuang, M.R. Emmert-Buck, S.C. Chandrasekharappa, P. Manickam, S.C. Guru, S.J. Marx, M.C. Skarulis, A.M. Spiegel, F.S. Collins et al., Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res. 57(11), 2238–2243 (1997)
O. Hessman, B. Skogseid, G. Westin, G. Akerstrom, Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. J. Clin. Endocrinol. Metab. 86(3), 1355–1361 (2001)
X.H. Jiang, J.L. Lu, B. Cui, Y.J. Zhao, W.Q. Wang, J.M. Liu, W.Q. Fang, Y.N. Cao, Y. Ge, C.X. Zhang et al., MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1. Endocr. Relat. Cancer 14(4), 1073–1079 (2007)
P. Manickam, S.C. Guru, L.V. Debelenko, S.K. Agarwal, S.E. Olufemi, J.M. Weisemann, M.S. Boguski, J.S. Crabtree, Y. Wang, B.A. Roe et al., Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum. Genet. 101(1), 102–108 (1997)
R.A. DeLellis, Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features. Lab. Invest. 72(5), 494–505 (1995)
S. Melmed, Hereditary endocrine tumors. Curr. Ther. Endocrinol. Metab. 5, 576–578 (1994)
P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio et al., Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J. Clin. Endocrinol. Metab. 90(5), 2603–2609 (2005)
A. Sakurai, S. Suzuki, S. Kosugi, T. Okamoto, S. Uchino, A. Miya, T. Imai, H. Kaji, I. Komoto, D. Miura et al., Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin. Endocrinol. (Oxf) 76(4), 533–539 (2012)
W.F. Simonds, S. Varghese, S.J. Marx, L.K. Nieman, Cushing’s syndrome in multiple endocrine neoplasia type 1. Clin. Endocrinol. (Oxf) 76(3), 379–386 (2012)
A.A. Ghazi, A.A. Dezfooli, F. Mohamadi, S.V. Yousefi, A. Amirbaigloo, S. Ghazi, M. Pourafkari, D. Berney, S. Ellard, A.B. Grossman, Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1. Endocr. Pract. 17(4), e92–e96 (2011)
J. Takagi, K. Otake, M. Morishita, H. Kato, N. Nakao, K. Yoshikawa, H. Ikeda, Y. Hirooka, Y. Hattori, C. Larsson et al., Multiple endocrine neoplasia type I and Cushing’s syndrome due to an aggressive ACTH producing thymic carcinoid. Intern. Med. 45(2), 81–86 (2006)
M. Yano, I. Fukai, Y. Kobayashi, K. Mizuno, A. Konishi, H. Haneda, E. Suzuki, K. Endo, Y. Fujii, ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1. Ann. Thorac. Surg. 81(1), 366–368 (2006)
J. Xiaohua, Clinical and basic research of multiple endocrine neoplasia. Doctor: Shanghai Jiao Tong Univesity, http://d.g.wanfangdata.com.cn/Thesis_Y1052781.aspx (2007)
R.V. Thakker, Multiple endocrine neoplasia type 1 (MEN1). Best Pract. Res. Clin. Endocrinol. Metab. 24(3), 355–370 (2010)
M.C. Lemos, R.V. Thakker, Multiple endocrine neoplasia type 1 (MEN1): analysis of 1,336 mutations reported in the first decade following identification of the gene. Hum. Mutat. 29(1), 22–32 (2008)
R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi, Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97(9), 2990–3011 (2012)
B.M. Cavaco, R. Domingues, M.C. Bacelar, H. Cardoso, L. Barros, L. Gomes, M.M. Ruas, A. Agapito, A. Garrao, A.A. Pannett et al., Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin. Endocrinol. (Oxf) 56(4), 465–473 (2002)
A. Karhu, L.A. Aaltonen, Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum. Mol. Genet. 16(Spec no. 1), R73–R79 (2007)
S.K. Agarwal, C.M. Mateo, S.J. Marx, Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J. Clin. Endocrinol. Metab. 94(5), 1826–1834 (2009)
Acknowledgments
The present study would not have been possible without the participation of the patients and their family members. The authors thank the department of endocrinology and metabolism of Ruijin hospital for providing clinical information of the proband. The study was supported by the National Natural Science Foundation of China (Nos. 81000333 and 30800562).
Conflict of interest
The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethical standard
This study was approved by the medical ethics committee of Shanghai First People’s Hospital. All participants who participated in this research gave written informed consent.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Xiaohua Li and Jing Su contributed equally to this work and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Li, X., Su, J., Zhao, L. et al. Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred. Endocrine 47, 183–190 (2014). https://doi.org/10.1007/s12020-013-0141-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0141-6